GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis AS (OTCPK:NVZMY) » Definitions » Price-to-Free-Cash-Flow

Novonesis AS (Novonesis AS) Price-to-Free-Cash-Flow

: 49.96 (As of Today)
View and export this data going back to 2009. Start your Free Trial

As of today (2024-04-19), Novonesis AS's share price is $54.46. Novonesis AS's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.09. Hence, Novonesis AS's Price-to-Free-Cash-Flow Ratio for today is 49.96.

The historical rank and industry rank for Novonesis AS's Price-to-Free-Cash-Flow or its related term are showing as below:

NVZMY' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 16.4   Med: 40.43   Max: 166.02
Current: 51.23

During the past 13 years, Novonesis AS's highest Price-to-Free-Cash-Flow Ratio was 166.02. The lowest was 16.40. And the median was 40.43.

NVZMY's Price-to-Free-Cash-Flow is ranked worse than
79.61% of 819 companies
in the Chemicals industry
Industry Median: 18.51 vs NVZMY: 51.23

Novonesis AS's Free Cash Flow per Share for the three months ended in Dec. 2023 was $0.27. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $1.09.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Novonesis AS was 88.40% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was -14.60% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was -6.40% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was -1.40% per year.

During the past 13 years, Novonesis AS's highest 3-Year average Free Cash Flow per Share Growth Rate was 40.70% per year. The lowest was -19.50% per year. And the median was 5.00% per year.


Novonesis AS Price-to-Free-Cash-Flow Historical Data

The historical data trend for Novonesis AS's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis AS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 42.48 28.86 53.35 87.89 49.20

Novonesis AS Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Free-Cash-Flow Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 87.89 158.99 143.78 62.64 49.20

Competitive Comparison

For the Specialty Chemicals subindustry, Novonesis AS's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novonesis AS Price-to-Free-Cash-Flow Distribution

For the Chemicals industry and Basic Materials sector, Novonesis AS's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Novonesis AS's Price-to-Free-Cash-Flow falls into.



Novonesis AS Price-to-Free-Cash-Flow Calculation

Novonesis AS's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=54.46/1.09
=49.96

Novonesis AS's Share Price of today is $54.46.
Novonesis AS's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.09.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Novonesis AS  (OTCPK:NVZMY) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Novonesis AS Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Novonesis AS's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Novonesis AS (Novonesis AS) Business Description

Address
Krogshoejvej 36, Bagsvaerd, DNK, 2880
Novozymes is the world leader in industrial enzymes. In recent years, the company has expanded into micro-organisms, primarily for agricultural markets. The firm supplies five major industry groups: household care, food and beverages, bioenergy, agriculture and feed, and technical and pharma. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark.

Novonesis AS (Novonesis AS) Headlines

From GuruFocus

Novozymes A/S's Dividend Analysis

By GuruFocus Research 10-19-2023

2 Holdings to Reduce Based on Analyst Recommendations

By Alberto Abaterusso Alberto Abaterusso 11-06-2019

Not Just Yogurt Anymore

By PRNewswire 10-26-2023